期刊文献+

In Vitro Study of Ultrasound on Multidrug Resistance in MDR Human Hepatoma HepG_2 Cells

In Vitro Study of Ultrasound on Multidrug Resistance in MDR Human Hepatoma HepG_2 Cells
下载PDF
导出
摘要 OBJECTIVE The aim of the study was to examine the reversal effects of ultrasound (US) on the MDR in HepG2/ADM, a HepG2 cell line resistant to Adriamycin (ADM), and to study the mechanism of US action.METHODS Using the MTT assay, the effects of US on MDR in HepG2/ADR cells were studied. Before and after the treatment with 0.5 W/cm^2 low intensity ultrasound (LIUS), the expression of the MDR-related genes, mdrl, mrp and lrp was assayed with the reverse transcriptase polymerase chain reaction (RT-PCR) and the levels of their respective protein expression determined by flow cytometry. By using confocal laser scanning microscopy (CLSM), we examined the intracellular daunorubicin (DNR) distribution, and the effects on the cells of treatment with US or DNR.RESULTS LIUS significantly reversed MDR in HepG2/ADR cells. After treatment with LIUS at 0.5 W/cm^2, chemosensitivity to ADM and DNR increased 3.35-fold and 2.81-fold, respectively. The reversal activity by LIUS plus verapamil (VER) was stronger than with either US or VER alone. After treatment with 0.5 W/cm^2, the expression of both the MDR1 and the MRP mRNA genes began to decline (P 〈 0.01 and P 〈 0.05, respectively); the expression of LRP showed no significant changes. Changes in the expression of the P-glycoprotein (P-gp) and MRP were similar to those of their mRNA expressions. Results of the CLSM showed that administration of US (0. 5 W/cm^2) or VER (15.7 uM) with DNR to HepGa/ADM cells showed a significant change in the distribution of DNR in the cells.CONCLUSION Our results show that LIUS can reverse MDR. The reversal effects are stronger than those of either US or VER alone, when combined with VER administration. As LIUS is noninvasive causing no toxicity, it might have potential for clinical application. The reversal mechanism needs further study. OBJECTIVE The aim of the study was to examine the reversal effects of ultrasound(US) on the MDR in HepG2/ADM,a HepG2 cell line resistant to Adriamycin(ADM),and to study the mechanism of US action.METHODS Using the MTT assay,the effects of US on MDR in HepG2/ADR cells were studied.Before and after the treatment with 0.5W/cm2 low intensity ultrasound(LIUS),the expression of the MDR-related genes,mdr1,mrp and lrp was assayed with the reverse transcriptase polymerase chain reaction(RT-PCR)and the levels of their respective protein expression determined by flow cytometry.By using confocal laser scanning microscopy(CLSM),we examined the intracellular daunorubicin (DNR) distribution,and the effects on the cells of treatment with US or DNR. RESULTS LIUS significantly reversed MDR in HepG2/ADR cells.A er treatment with LIUS at 0.5W/cm2,chemosensitivity to ADM and DNR increased 3.35-fold and 2.81-fold,respectively.The reversal activity by LIUS plus verapamil(VER) was stronger than with either US or VER alone.A er treatment with 0.5W/cm2 ,the expression of both the MDR1 and the MRP mRNA genes began to decline(P<0.01 and P<0.05,respectively);the expression of LRP showed no significant changes.Changes in the expression of the P-glycoprotein(P-gp) and MRP were similar to those of their mRNA expressions.Results of the CLSM showed that administration of US(0.5W/cm2) or VER(15.7μM) with DNR to HepG2/ADM cells showed a significant change in the distribution of DNR in the cells. CONCLUSION Our results show that LIUS can reverse MDR. The reversal effects are stronger than those of either US or VER alone,when combined with VER administration.As LIUS is non-invasive causing no toxicity,it might have potential for clinical application.The reversal mechanism needs further study.
出处 《Chinese Journal of Clinical Oncology》 CSCD 2008年第3期165-171,共7页 中国肿瘤临床(英文版)
基金 a grant from National Natural Science Foundation of China (No.30200060)
关键词 multidrug resistance (MDR) HEPG2/ADM ultra-sound (US) reversal. 肝细胞瘤 多药抗性 HepG2/ADM 超声诊断
  • 相关文献

参考文献13

  • 1翟宝进,伍烽,邵泽勇,胡凯,王智彪.阿霉素诱导人肝癌细胞多药耐药株的建立及其生物学特性评价[J].癌症,2004,23(4):391-395. 被引量:20
  • 2翟宝进,伍烽,邵泽勇,胡凯,赵纯亮,王智彪.人肝癌多药耐药细胞株的建立及超声波诱导凋亡的研究[J].中华肝脏病杂志,2004,12(2):95-98. 被引量:13
  • 3翟宝进,邵泽勇,伍烽,王智彪.HIFU逆转人肝癌细胞HepG2/Adm多药耐药的实验研究[J].癌症,2003,22(12):1284-1288. 被引量:18
  • 4Gottesman MM,Fojo T,Bates SE.Multidrug resistancein cancer:role of ATP-dependent transporters[].Cancer.2002
  • 5Tsuruo T,Iida H,Nojiri M,et al.High calcium contentof pleiotropic drug-resistant P388 and K562 leukemiaand Chinese hamster ovary cells[].Cancer Research.1983
  • 6Ford JM,Hait WN.Pharmacology of drugs that altermultidrug resistance in cancer[].Pharmacology Reviews.1991
  • 7Barrand MA,Phodes T,Center MS,et al.Chemosensi-tisation and drug accumulation effects of cyclosporinA,PSC-833 and verapamil in human MDR large celllung cancer cells expressing a 190k membrane pro-tein distinct from P-glycoprotein[].European Journal of Cancer.1993
  • 8Harrison GH,Balcer-Kubiczek EK,Gutierrez PL.In vitroaction of continuous-wave ultrasound combined withadriamycin,X-rays or hyperthemia[].Radiation Research.1996
  • 9Williams AR.Ultrasound:Biological Effects and Poten-tial Hazards[]..1983
  • 10.Biological effects of ultrasound:mechanisms and clinical implications[].NCRP Report No.1983

二级参考文献12

  • 1梁正东,卞度宏.卵巢癌细胞对顺铂耐药及其逆转的实验研究[J].中华妇产科杂志,1996,31(2):75-78. 被引量:21
  • 2Larsen AK,Escargueil AE,Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents [J]. Pharmacol Ther,2000,85(3):217- 229.
  • 3Yang LY,Trujillo JM. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods [J]. Cancer Res,1990,50:3218- 3225.
  • 4Morkve O,Laerum OD. Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas [J]. Cytometry,1991,12:438- 444.
  • 5Grude P,Conti F,Mennecier D,et al. MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis [J]. Cancer Lett, 2002,186(1):107- 113.
  • 6Noskova V,Dzubak P,Kuzmina G,et al. In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells [J]. Neoplasma,2002,49(6):418- 425.
  • 7Gottesman MM,Fojo T,Bates SE.Multidrug resistance in cancer:role of ATP-dependent transporters [J]. Cancer,2002,2(1):48- 58.
  • 8Schneider E,Yamazaki H,Sinha BK,et al. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation [J]. Br J Cancer, 1995,71(4):738- 743.
  • 9Schrenk D,Baus PR,Ermel N,et al. Up-regulation of transporters of the MRP family by drugs and toxins [J]. Toxicol Lett, 2001,120(1- 3):51- 57.
  • 10Siva AC,Raval-Fernandes S,Stephen AG,et al. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance [J]. Int J Cancer,2001,92(2):195- 202.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部